Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: pushing the forefront of neuromodulation with functional network mapping, biomarkers for adaptive DBS, bioethical dilemmas, AI-guided neuromodulation, and translational advancements
Year: 2024
Type: article
Abstract: The Deep Brain Stimulation (DBS) Think Tank XI was held on August 9-11, 2023 in Gainesville, Florida with the theme of "Pushing the Forefront of Neuromodulation". The keynote speaker was Dr. Nico Dosenbach from Washington University in St. Louis, Missouri. He presented his research recently published in Nature inn a collaboration with Dr. Evan Gordon to identify and characterize the somato-cognitive action network (SCAN), which has redefined the motor homunculus and has led to new hypotheses about the integrative networks underpinning therapeutic DBS. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers, and researchers (from industry and academia) can freely discuss current and emerging DBS technologies, as well as logistical and ethical issues facing the field. The group estimated that globally more than 263,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. This year's meeting was focused on advances in the following areas: cutting-edge translational neuromodulation, cutting-edge physiology, advances in neuromodulation from Europe and Asia, neuroethical dilemmas, artificial intelligence and computational modeling, time scales in DBS for mood disorders, and advances in future neuromodulation devices.
Source: Frontiers in Human Neuroscience
Authors: Kara A. Johnson, Nico U. F. Dosenbach, Evan M. Gordon, Cristin G. Welle, Kevin B. Wilkins, Helen M. Bronte-Stewart, Valerie Voon, Takashi Morishita, Yuki Sakai, Amanda R. Merner, Gabriel Lázaro-Muñoz, Theresa Williamson, Andreas Horn, Ro'ee Gilron, Jonathan O'Keeffe, Aryn H. Gittis, Wolf-Julian Neumann, Simon Little, Nicole R. Provenza, Sameer A. Sheth, Alfonso Fasano, Abbey B. Holt-Becker, Robert S. Raike, Lisa Moore, Yagna J. Pathak, David Greene, Sara Marceglia, Lothar Krinke, Huiling Tan, Hagai Bergman, Monika Pötter-Nerger, Bomin Sun, Laura Y. Cabrera, Cameron C. McIntyre, Noam Harel, Helen S. Mayberg, Andrew D. Krystal, Nader Pouratian, Philip A. Starr, Kelly D. Foote, Michael S. Okun, Joshua K. Wong
Institutions: University of Florida Health, University of Florida, Washington University in St. Louis, University of Colorado Anschutz, University of Colorado Denver, Stanford Medicine, Stanford University, University of Cambridge, Fukuoka University, Kyoto Prefectural University of Medicine, Advanced Telecommunications Research Institute International, Harvard University, Massachusetts General Hospital, Brigham and Women's Hospital, Humboldt-Universität zu Berlin, Freie Universität Berlin, Charité - Universitätsmedizin Berlin, Rune Labs (United States), Center for the Neural Basis of Cognition, Carnegie Mellon University, University of California, San Francisco, Baylor College of Medicine, University Health Network, University of Toronto, Toronto Western Hospital, Krembil Brain Institute, Medtronic (United States), Boston Scientific (United States), Abbott (United States), NeuroPace (United States), University of Trieste, West Virginia University, University of Oxford, MRC Brain Network Dynamics Unit, Hebrew University of Jerusalem, Hadassah Medical Center, University Medical Center Hamburg-Eppendorf, Shanghai Jiao Tong University, Ruijin Hospital, Pennsylvania State University, Duke University, University of Minnesota, Icahn School of Medicine at Mount Sinai, The University of Texas Southwestern Medical Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,295
Funders: Abbott Laboratories, University of Florida Foundation, Bachmann-Strauss Dystonia and Parkinson Foundation, Hope for Depression Research Foundation, Vanderbilt University, University of Florida, Boston Scientific Corporation, Japan Agency for Medical Research and Development, Sunovion, Wellcome Trust, Jazz Pharmaceuticals, Parkinson Alliance, EU Joint Programme – Neurodegenerative Disease Research, Parkinson's Foundation, Neurocrine Biosciences, Hope Center for Neurological Disorders, Harmony Biosciences, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Eisai, Fukuoka University, Association France Parkinson, Ipsen, Idorsia Pharmaceuticals, National Institutes of Health, Defense Advanced Research Projects Agency, Intellectual and Developmental Disabilities Research Center, Medical Research Council, Japan Society for the Promotion of Science, Central Research Institute, Fukuoka University, National Institute of Mental Health, National Institute of Nursing Research, National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering, National Center for Advancing Translational Sciences, Janssen Pharmaceuticals
Awards: G1105927947, G1152718569, G1192882743, G1271896228, G1322185500, G1583471066, G1810632041, G2137889659, The motor network in Parkinson's disease: Mechanisms of therapy, G2381784207, G2441995029, G2701466252, G2713572608, In vivo human addiction biomarkers: towards closed loop deep brain stimulation, G2779179651, G2785336682, G2899485316, G2989886852, G3138802406, G3304296203, G347275618, G348184033, G3642085636, G3779796333, University of Florida R25 Early Research Program for Neurology and Neurosurgery Residents, The Human Thalamocortical Network in Tourette Syndrome, 7 Tesla Terra Instrument, G4510041740, G4725624925, G4750422559, G4985167192, TRR 295: Behandlung motorischer Netzwerkstörungen mittels Neuromodulation, G6136248408, Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's disease, Development of methods for optimization of deep brain stimulation parameters by establishing the biomarders indicating severity in Parkinson's disease, Identification of outcome-based sub-populations using deep phenotyping and precision functional mapping across ADHD and ASD, 癌細胞膜に局在する機能蛋白質に関する研究, G6737372705, G674518674, G6886305284, G6912864445, G714724801, G7237721280, G7458042070, G7591693819, Algorithms for programming DBS systems for Essential Tremor, G7772632206, G7886710174, G816297615, G8638799456, G9000029478, G9000037945, G9000050007, G9000068389, G9000092617, G9000099078, G9000111797, G9000138211, G9000148177, G9000165475, G9000220761, G9000223197, G9000262551, G9000281429, G9000319168, G9000353058, Technology to Realize the Full Potential of UHF MRI, The role of myelination in cortical circuit function and motor behavior, Using Brain Lesions and Deep Brain Stimulation to Identify an Epilepsy Circuit, Toward Connectomic Deep Brain Stimulation in Obsessive Compulsive Disorder, BRAIN CONNECTS: The center for Large-scale Imaging of Neural Circuits (LINC), Deep Brain Stimulation for Depression Using Directional Current Steering and Individualized Network Targeting, 計算論モデルと脳神経画像解析によるトゥレット症重症化機序の解明
OpenAlex ID: W4392018844